Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced with Fentanyl

In a Psychiatric Services Pages to Practice podcast, Dr. Joe Parks, the National Council’s medical director, joined co-hosts Dr. Lisa Dixon and Dr. Josh Berezin to discuss guidelines for clinicians on how to deal with the increased prevalence of drugs adulterated with fentanyl and similar potent fentanyl analogs.

Listen now: https://pagestopractice.libsyn.com/website/61-guidance-for-handling-the-increasing-prevalence-of-drugs-adulterated-or-laced-with-fentanyl

← Prev: Cannabis and Cannabinoids for Pain and PTSD in Military Personnel and Veterans Next: New CDC Report: Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine – U.S., January 2019-June 2022 →

FDA Recommends Concentrated Kratom Be Scheduled As Illicit Substance

October 14, 2025

The Trump Administration is recommending that a compound called 7-OH be scheduled as an illicit drug, Food and Drug...

Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study

October 10, 2025

Stimulant overdose deaths continue to rise, even as opioid overdoses decline—and there are still no FDA-approved...

NIH Study: Opioid Treatment in Jails Saves Lives

October 7, 2025

A study found that individuals who receive medications for opioid use disorder (MOUD) while incarcerated are more...

Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced with Fentanyl

You May Also Like…

FDA Recommends Concentrated Kratom Be Scheduled As Illicit Substance

Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study

NIH Study: Opioid Treatment in Jails Saves Lives

0 Comments

Submit a Comment Cancel reply